Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Roswell Park Cancer Institute, Buffalo

Walt Disney Memorial Cancer Institute, Orlando

Baptist Hospital of East Tennessee, Knoxville

St. Joseph's Regional Medical Center, South Bend

University of Iowa Hospitals and Clinics, Iowa City

Ellis Fischel Cancer Center, Columbia

Texas Oncology, P.A., Dallas

University of Texas Southwestern Medical Center at Dallas, Dallas

Gynecologic Oncology Associates, Newport Beach

Stanford University Medical Center, Stanford

Swedish Medical Center Tumor Institute, Seattle

Parker Hill Oncology & Hematology, Boston

Tom Baker Cancer Centre, Calgary

Cancer Care Manitoba, Winnipeg

Ottawa Regional Cancer Centre, Ottawa

Centre Hospitalier Universitaire de Sherbrooke - Hopital Fleurimont, Fleurimont

SMBD Jewish General Hospital, Montreal